Corrigendum: targeting myeloid checkpoint molecules in combination with antibody therapy: a novel anti-cancer strategy with iga antibodies?

HIGHLIGHTS

• who: Chilam Chan and collaborators from the Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany have published the Article: Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?, in the Journal: (JOURNAL)

SUMMARY

IgA, myeloid checkpoints, neutrophils (PMNs), cancer immonotherapy, immune checkpoint, antibodies, CD47-SIRPalpha axis, macrophages A Corrigendum on COPYRIGHT Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies? by Chan C, Lustig . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.